- Asbestos
- Class Actions
- Commercial Litigation
- Defective Products
- Drug Injury
- Personal Injury
- Securities Fraud
- Toxic Exposure
- Accutane Side Effects
- Darvon and Darvocet
- DePuy Hip Recall
- Fosamax Femur Fractures
- Muscle Injury
- Sleeping Pill Dangers
- SSRI Birth Defects
- Topamax Birth Defects
- Transvaginal Surgical Mesh and Bladder Slings
- Tylenol Liver Damage
- Zocor/Simvastatin
Pending Settlements
Merck Faces Another Fosamax Drug Injury Suit
In an Illinois circuit court, two women have filed a drug injury lawsuit against pharmaceutical giant, Merck Sharp & Dohme Corporation. Beth Tobias and Margaret Freiberg both took Fosamax, a drug manufactured by Merck to help prevent fractures in women with osteoporosis. However, both Tobias and Freiberg allege that Fosamax had the opposite effect on them, weakening their bones and actually increasing their risk of bone injury. Read the full story.
Calling on our experience in drug injury cases, including a $4.85 billion dollar settlement in a case involving another Merck drug, Vioxx, Seeger Weiss is currently taking on new Fosamax cases. Visit our Fosamax Investigation Page to learn more.

